AI-generated summary
In a mouse model of rosacea, the authors studied photobiomodulation therapy using 590 nm and 830 nm light. They report that the therapy reduced erythema and inflammatory cell infiltration and lowered markers of inflammation and blood vessel formation. The findings come from an animal study, and the authors conclude the therapy may improve rosacea-like lesions in mice.
- Who or what was studied
- Female BALB/c mice in a rosacea model induced by LL-37 injection
- Wavelengths
- 590, 830 nm
- Limits stated in the abstract
- The evidence is from a mouse model, and the abstract reports no human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on atm.amegroups.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm, 590 nm
- Power
- 25 mW, 50 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Angiogenesis, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.